Luigi Mangione returns to Manhattan federal court Monday to face stalking charges in the killing of UnitedHealthcare CEO Brian Thompson — a case that lays bare a justice system where the federal government mobilizes for a corporate executive while ordinary Americans are left under the thumb of progressive prosecutors who refuse to lock up violent repeat offenders.
The Department of Justice under President Trump swooped in with death-penalty-eligible federal charges after Mangione's arrest — not because most killers get federal treatment, but because, as the New York Post reported, "outraged health industry leaders" demanded it. The vast majority of murder defendants in Manhattan never see a federal courtroom. But when the victim is a Fortune 500 executive, Washington finds resources it can't seem to locate for the families in Bragg's jurisdiction who bury loved ones killed by criminals with long rap sheets the DA already chose not to prosecute.
Mangione, 28, stands accused of shooting Thompson, 50, on a Midtown sidewalk December 4, 2024, outside UnitedHealth's annual investor conference. Bullet casings at the scene bore the words "delay" and "deny" — a reference to insurer tactics for avoiding claim payouts. He led police on a five-day manhunt before being arrested in Altoona, Pennsylvania, at a McDonald's. He has pleaded not guilty in both his state and federal cases and is held without bail at the Metropolitan Detention Center in Brooklyn.
The state case, prosecuted by Manhattan District Attorney Alvin Bragg, charges Mangione with murder and weapons offenses. Jury selection is set for September 8. The federal case — where a judge has already tossed the death-penalty-eligible murder charge, leaving only stalking counts — is currently scheduled for October, though US District Judge Margaret Garnett has signaled openness to pushing it to winter or early 2027. The two trial schedules now collide.
Meanwhile, Mangione's defense strategy remains in flux. Judge Gregory Carro, overseeing the state case, revealed June 17 that Mangione's lawyers initially planned an "extreme emotional disturbance" psychiatric defense. Lead attorney Karen Friedman Agnifilo argued in a sealed proceeding that such a defense essentially amounts to a public admission of guilt — "if a defendant goes with an EED defense, they're essentially admitting publicly that they committed this crime," she said, according to a transcript unsealed June 18.
The defense then withdrew the formal psychiatric notice. The Guardian framed this as a full abandonment of the EED strategy; the Post called the reversal "bizarre." But a legal expert told The Guardian that Mangione could still argue mental distress at trial without the formal notice — potentially by taking the stand or using prosecutors' own evidence — in a bid to secure a manslaughter conviction instead of murder.
Carro also held a closed-door conference on June 3 despite press requests for access, then declined to unseal the record after the psychiatric notice was withdrawn — keeping the public in the dark about proceedings that are presumptively open under both New York state and federal law.
So the picture is this: a wealthy Ivy League scion charged with assassinating a healthcare CEO gets two full prosecutorial trackings — one from Bragg's office, one from the feds — while the same Manhattan DA's office routinely cuts deals that put violent offenders back on the street. The DOJ found time and jurisdiction for a stalking case against one killer because the health industry asked. Working-class New Yorkers might reasonably ask who shows up when it's their family on the sidewalk.
